GROUP ONE TRADING, L.P. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 142 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$147,191
-61.6%
4,655
-50.5%
0.00%
-100.0%
Q2 2023$383,577
-16.5%
9,406
-28.6%
0.00%0.0%
Q4 2022$459,432
-67.0%
13,168
-51.1%
0.00%
-50.0%
Q2 2022$1,392,000
-69.5%
26,901
-4.6%
0.00%
-66.7%
Q2 2021$4,567,000
+260.5%
28,210
+78.7%
0.01%
+200.0%
Q1 2021$1,267,000
+277.1%
15,787
+155.7%
0.00%
+100.0%
Q4 2020$336,000
+131.7%
6,175
-47.9%
0.00%0.0%
Q1 2020$145,000
+4.3%
11,845
+25.3%
0.00%0.0%
Q4 2019$139,000
-8.6%
9,454
-17.1%
0.00%0.0%
Q3 2019$152,000
+700.0%
11,403
+901.1%
0.00%
Q2 2019$19,000
-83.0%
1,139
-82.6%
0.00%
-100.0%
Q1 2019$112,000
+43.6%
6,539
+13.9%
0.00%0.0%
Q4 2018$78,000
+20.0%
5,739
+151.0%
0.00%0.0%
Q3 2018$65,000
-80.5%
2,286
-81.2%
0.00%
-66.7%
Q2 2018$333,000
-81.7%
12,174
-85.9%
0.00%
-83.3%
Q1 2018$1,816,000
+143.1%
86,090
+121.5%
0.02%
+260.0%
Q4 2017$747,000
+295.2%
38,867
+411.1%
0.01%
+150.0%
Q3 2017$189,000
-11.7%
7,605
-43.1%
0.00%0.0%
Q2 2017$214,000
+74.0%
13,372
+53.7%
0.00%
+100.0%
Q1 2017$123,0008,7000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 752,024$100,884,00018.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 420,859$56,458,0004.40%
Discovery Value Fund 922,411$123,741,0003.63%
MPM BioImpact LLC 162,620$21,815,0003.38%
Ally Bridge Group (NY) LLC 65,000$8,720,0002.56%
ARK Investment Management 6,743,556$904,648,0002.17%
Integral Health Asset Management, LLC 50,000$6,708,0001.93%
Yorktown Management & Research Co Inc 18,300$2,455,0001.85%
Interchange Capital Partners, LLC 8,191$1,098,0001.84%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$14,950,0001.76%
View complete list of INTELLIA THERAPEUTICS INC shareholders